Polymer-drug Conjugates Market – Regional Analysis
On the basis of region, the global polymer-drug conjugates market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is projected to hold dominant position in the global polymer-drug conjugates
market due to increase in number of clinical trials in the U.S. For instance, in January 2018,
Apellis Pharmaceuticals announced to conduct phase III clinical study for APL-2 in the U.S.
APL-2 is a synthetic cyclic peptide drug conjugated to a polyethylene glycol polymer for the
treatment of geographic atrophy associated with age-related macular degeneration.
Furthermore, increasing research on novel Drug Delivery Systems (DDS) in Asia Pacific is
expected to contribute to significant growth of the polymer drug conjugates market in the
region during the forecast period. For instance, in August 2018, Osaka University, in
collaboration with Tokyo Institute of Technology, Japan, developed a DDS using polyethylene
glycol and polylysine block copolymer, with ubenimex conjugate (PEG-b-PLys (Ube). Intravenous
injection of ubenimex with these polymers in mice, found to reduce the tumor size significantly.
Such results are expected to be a positive traction for growth of the market during the forecast
period.
Report includes chapters which deeply display the following deliverable about industry :
• Polymer-drug Conjugates Market Research Objective and Assumption
• Polymer-drug Conjugates Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Polymer-drug Conjugates Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Polymer-drug Conjugates Market, By Regions
• Polymer-drug Conjugates Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Polymer-drug Conjugates Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Polymer-drug Conjugates Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer